What Is Familial Hypercholesterolemia, and Why Does It Matter?
作者信息
Khera Amit V, Hegele Robert A
机构信息
Center for Genomic Medicine and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (A.V.K.).
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (A.V.K.).
出版信息
Circulation. 2020 Jun 2;141(22):1760-1763. doi: 10.1161/CIRCULATIONAHA.120.046961. Epub 2020 Jun 1.
Abstract
摘要
相似文献
1
What Is Familial Hypercholesterolemia, and Why Does It Matter?
Circulation. 2020 Jun 2;141(22):1760-1763. doi: 10.1161/CIRCULATIONAHA.120.046961. Epub 2020 Jun 1.
2
Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?
Trends Cardiovasc Med. 2021 May;31(4):216-217. doi: 10.1016/j.tcm.2020.04.001. Epub 2020 May 11.
3
What Is the Prevalence of Familial Hypercholesterolemia?
Arterioscler Thromb Vasc Biol. 2021 Oct;41(10):2629-2631. doi: 10.1161/ATVBAHA.121.316862. Epub 2021 Aug 26.
4
Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Circ Cardiovasc Genet. 2016 Dec;9(6):504-510. doi: 10.1161/CIRCGENETICS.116.001545. Epub 2016 Oct 26.
5
Familial hypercholesterolemia diagnostic challenge: Is Artificial Intelligence the key?
Atherosclerosis. 2024 Apr;391:117435. doi: 10.1016/j.atherosclerosis.2023.117435. Epub 2023 Dec 27.
6
Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2508-2515. doi: 10.1161/ATVBAHA.120.313722. Epub 2020 Aug 6.
7
Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
Curr Opin Lipidol. 2019 Apr;30(2):82-87. doi: 10.1097/MOL.0000000000000573.
8
A familial hypercholesterolemia week in Kyrgyzstan: The joint scientific and practical symposium with the European Atherosclerosis Society (EAS), the International Atherosclerosis Society (IAS) and the Kyrgyz Society of Cardiology (KSC).
Atherosclerosis. 2019 Feb;281:198-199. doi: 10.1016/j.atherosclerosis.2018.11.036. Epub 2018 Dec 3.
9
Clinical features, diagnosis and frequency of familial hypercholesterolemia.
Beitr Infusionsther. 1988;23:26-32.
10
Familial hypercholesterolemia: genetic predisposition to atherosclerosis.
Medsurg Nurs. 2004 Aug;13(4):253-7.
引用本文的文献
1
Assessment of Primary Health Care Physicians' Awareness, Knowledge, and Practice of Familial Hypercholesterolemia in Jazan, Saudi Arabia.
Cureus. 2025 Jul 9;17(7):e87625. doi: 10.7759/cureus.87625. eCollection 2025 Jul.
2
Beyond identification of familial hypercholesterolemia: Improving downstream visits and treatments in a large health care system: Improving FH Care.
Am J Prev Cardiol. 2025 Jan 24;21:100937. doi: 10.1016/j.ajpc.2025.100937. eCollection 2025 Mar.
3
Development and implementation of a digiphysical screening model with nationwide reach to diagnose familial hypercholesterolemia.
Digit Health. 2025 Jan 23;11:20552076241311156. doi: 10.1177/20552076241311156. eCollection 2025 Jan-Dec.
4
Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.
Commun Biol. 2024 Apr 23;7(1):489. doi: 10.1038/s42003-024-06121-9.
5
Aortic Wall Thickness as a Surrogate for Subclinical Atherosclerosis in Familial and Nonfamilial Hypercholesterolemia: Quantitative 3D Magnetic Resonance Imaging Study and Interrelations with Computed Tomography Calcium Scores, and Carotid Ultrasonography.
J Clin Med. 2023 Aug 27;12(17):5589. doi: 10.3390/jcm12175589.
6
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.
Nat Rev Cardiol. 2023 Dec;20(12):845-869. doi: 10.1038/s41569-023-00892-0. Epub 2023 Jun 15.
7
The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review.
Front Genet. 2022 Dec 6;13:1072108. doi: 10.3389/fgene.2022.1072108. eCollection 2022.
8
Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab.
Biomedicines. 2022 Dec 16;10(12):3273. doi: 10.3390/biomedicines10123273.
9
Prevalence of familial hypercholesterolemia in patients with confirmed premature coronary artery disease in Ranchi, Jharkhand.
Egypt Heart J. 2022 Dec 17;74(1):83. doi: 10.1186/s43044-022-00320-7.
10
Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.
Int J Mol Sci. 2022 Nov 29;23(23):14971. doi: 10.3390/ijms232314971.
本文引用的文献
1
Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Circulation. 2020 Jun 2;141(22):1742-1759. doi: 10.1161/CIRCULATIONAHA.119.044795. Epub 2020 May 29.
2
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.
JAMA Cardiol. 2020 Apr 1;5(4):390-399. doi: 10.1001/jamacardio.2019.5954.
3
Cholesterol-Lowering Agents.
Circ Res. 2019 Feb;124(3):364-385. doi: 10.1161/CIRCRESAHA.118.313238.
4
The complex molecular genetics of familial hypercholesterolaemia.
Nat Rev Cardiol. 2019 Jan;16(1):9-20. doi: 10.1038/s41569-018-0052-6.
5
Familial hypercholesterolaemia.
Nat Rev Dis Primers. 2017 Dec 7;3:17093. doi: 10.1038/nrdp.2017.93.
6
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
7
Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
Science. 2016 Dec 23;354(6319). doi: 10.1126/science.aaf7000.
8
Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2439-2445. doi: 10.1161/ATVBAHA.116.308027. Epub 2016 Oct 20.
9
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
J Am Coll Cardiol. 2016 Jun 7;67(22):2578-89. doi: 10.1016/j.jacc.2016.03.520. Epub 2016 Apr 3.
10
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
Eur Heart J. 2016 May 1;37(17):1384-94. doi: 10.1093/eurheartj/ehw028. Epub 2016 Feb 22.
Zotero 插件